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Summary-(-) Nicotine, in doses of OG%O~Ol mg/kg given intravenously over 1 min, 
produced transient behavioral arousal and EEG activation in cats with chronic indwelling 
brain electrodes. The effects of nicotine were evident when the animals were in natural 
slow wave (deep) sleep as observed behaviorally and by the EEG with recordings from various 
cortical and subcortical sites. After nicotine administration, the animals were aroused for 
a few minutes and later became sleepy behaviorally and showed EEG slow waves. This was 
frequently followed by activated or fast wave sleep. This phenomenon was not evident 
following infusion of equal volumes of warmed saline solution. In equal doses (+) nicotine, 
nicotine-N-oxide and cotinine did not affect EEG and behavior in slow wave sleeping cats. 
However, equipressor doses of (+) nicotine (0.05 mg/kg) and nicotine-N-oxide (1.5 mg/kg) 
produced slight behavioral and EEG arousal in cats with slow wave sleep. Massive doses of 
cotinine (2.5 mg/kg) given intravenously were less effective than (-) nicotine in doses of 
0.01 mg/kg. Equipressor doses of epinephrine (E) (0402 mg/kg), phenylalanyl lysine vaso- 
pressin (50 milliunits/kg) and DMPP (04XtS mg/kg) produced weaker EEG activation and 
behavioral arousal than ( -) nicotine. 
Pretreatment with trimethidinium (2 mg/kg) prevented the cardiovascular effects of 
nicotine but did not alter greatly its behavioral arousal or EEG activation effects. On the 
other hand, mecamylamine (0.6 mg/kg) completely blocked the cardiovascular actions of 
nicotine as well as its effects on EEG and behavior. Larger doses of mecamylamine interfered 
with the natural sleep cycle of the cat. By use of such pharmacologic techniques it is concluded 
that the behavioral arousal and EEG desynchronizing effects of nicotine are due primarily 
to an action on the central nervous system rather than peripheral afferent stimulation or 
release of various neurohormones. However, these latter effects contribute to the total 
phenomenon produced by nicotine in intact animals. 
INTRODUCTION 
WIDESPREAD peripheral autonomic effects make it difficult to determine the actions of 
nicotine directly on the central nervous system. Investigators have reported that nicotine 
in subconvulsive doses produces EEG desynchronization in rabbits (LONGO et al., 1954; 
SILVESTRINI, 1958; STUMPF, 1959; DUNLOP et al., 1960; SILVETTE et al., 1962). FLORIS 
et al, (1962) reported that large doses of nicotine produce EEG desynchronization or 
seizure discharges in mesencephalic transected rabbits. These investigators suggested 
that the origin of seizure discharges was in the hippocampus. Most studies on the central 
actions of nicotine have been made using fairly large doses. In contrast, KNAPP and 
DOMINO (1961-1963) showed that nicotine in doses of 0.01 to 0.02 mg/kg given intra- 
venously to intracollicular, high pontine brainstem transected animals caused EEG desyn- 
chronization. EEG desynchronization was noted in acute brainstem transected rabbits, 
*A preliminary paper was presented before the American Society for Pharmacology and Experimental 
Therapeutics in Kansas City, August 1964 (YAMAMOTO and DOMINO, 1964). 
tsupported in part by The Council for Tobacco Research, USA, and NB-01311, USPHS. 
$Present address-Department of Neuropharmacology, Shionogi Research Laboratory, Osaka, Japan. 
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cats, dogs, and monkeys. These investigators demonstrated that nicotine-indu~d EEG 
desynchronization was due to an action on the central nervous system and not to stimula- 
tion of peripheral nerves or release of various neurohumoral substances. 
EEG studies in acute animals provide little information regarding the behavioral 
consequences of nicotine. In intact preparations, EEG desynchronization recorded from 
neocortical structures can occur in at least two different behavioral states. One is that 
associated with behavorial alertness or wakefulness and the other with activated, ‘para- 
doxical’ or fast wave phase of sleep (DEMENT and KLEITMAN, 1957; DEMENT, 1958 ; 
YA~AMOTO, 1959; YAMA~O~O and K~Do, 1962; JOUVET, 1961). In order to ascertain if 
the EEG desynchronizing actions of nicotine are related to behavioral arousal or to the 
activated phase of sleep, it was necessary to study the effects of nicotine in intact animals 
with chronically implanted brain electrodes. Various pharmacologic treatments were 
used in an attempt to demonstrate whether the actions of nicotine observed in such intact 
preparations were due primarily to periphera1 or central components. This manuscript 
describes some of the results obtained. 
Experiments were performed in fifteen cats with chronically indwelling brain electrodes 
utilizing a Latin square design for drug administration at 2-week intervals. Thecats were pre- 
pared for placement of indwelling electrodesusing modifications of conventional techniques. 
Adult cats of both sexes were used. Surgical preparation of the animals was under pento- 
barbital sodium anesthesia. Stainless steel wires of 0.22 mm in diameter (insulated except 
for tips of 0.5 mm) were used as the depth electrodes. Bipolar depth electrodes were 
inserted into the amygdala and ~ppocampus with the aid of the stereotaxic atlases by 
JASPER and AJMONE-MARSAN (1954) and SNIDER and NIEMER (1961). Physiologic recordings 
of injury discharges by insertion of electrodes were used for location of the hippocampus 
and olfactory-induced waves for the amygdala. Bipolar silver ball electrodes of 0.5 mm 
in diameter were applied as epidural surface electrodes to the somatosensory cortex. 
Additional depth electrodes were occasionally placed in the posterior hypothalamus and 
mesencephalic reticular formation. Each electrode was soldered to a Cannon plug and 
fixed on the scalp by means of dental cement. Silastic tubing of 0.7 mm in diameter was 
inserted into the right jugular vein with the other end fixed to a connector on top of the 
skull. The animals were allowed to recover for a 2-week period before being used for 
drug studies. In the meantime, they were given antibiotics prophylactically to reduce 
infection. At the time of the experiment, EMG of the posterior neck muscles, EKG and 
respiratory movements were recorded along with the brain waves on a Grass polygraph. The 
animals were each placed in a sound proof box with a one-way viewing window. Behavioral 
changes were observed and correlated with EEG activity. Crucial sequences of behavior 
were recorded on 16 mm movie film. In order to promote naturally occurring sleep, the 
animals were made as warm and comfortable as possible. With care and patience it was 
possible to observe all stages of natural sleep. 
The following drugs were administered as an intravenous infusion in saline solution 
over a one-minute period: (-) nicotine base, (+) nicotine base*, (+) nicotine ditartratet, 
*Kindly provided by Drs. W. STEPKA and P. LARSON, Department of Pharmacology, Medical College of 
Virginia, Richmond 19, Virginia. 
fKindly provided by Dr. R. B. BARLOW, Department of Pha~acology, University of Edinburgh Medical 
Schoot, Edjnbur~ 8, Scotland, 
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cotinine bases, cotinine fumarateq, nicotine-N-oxide:, epinephrine hydrochloride, phenyIa- 
lanyl lysyl vasopressin **, DMPPft, trimethidinium bismethosulfates:, mecamylamine 
hydr~hIoride~~, serotonin ereatinine sulfate and hista~ne phosp~te. Ah drugs were given 
in doses calculated as base. The actions of these drugs and various combinations on 
behavior were compared with each drug infused in a constant volume of l-5 ml over a 
I-min period. After completion of a series of experiments the positions of the electrodes 
were determined histologica~iy by the iron deposition technique (see DOWINO, 19.55 for 
detaifs). 
Blood pressures were measured in acute animals prepared under ether anesthesia and 
subsequently given a local anesthetic, I mgjkg of d~came~onium and artificial respiration 
at 300 ml of air/kg/min. 
RESULTS 
A. Lack ofesfects ofsaline solutio~z infusion on the EEG and behavior of the sleeping cat 
The normal EEG of the cat was classified on the basis of six behavioral levels: excited, 
alert, resting, drowsy-light sieep, stow wave (deep) sleep and activated (fast wave) sleep. The 
EEG and physiologic counterparts of these behavioral states have been described previously 
(YA~MOTO, 1959). Under the conditions of the present experiments utilizing a sound- 
proofed chamber in which the animals were made very comfortable, a naturally occurring 
deep sleeping state couid be obtained easily. During this period the animals showed 
a stable sleep pattern both in their EEG and behavior. Highvoltage slow waves of 1-3 c/s 
and spindle bursts in the somatosensory cortex, high voltage slow waves and spike-like 
discharges in the amygdaIa, and high vohage fast waves in the hippocampus were routinely 
observed. In addition, a minimal discharge of the EMG of the neck muscles and rhythmic 
respiration were recorded in such a sleeping state. These EEG and behavioral manifesta- 
tions of slow wave natural sleep were easily reversed by direct high frequency electrical 
stimulation of the mesencephalic reticular formation, posterior hypothafamus or by 
external stimuli such as a loud noise. All fifteen cats studied illustrated that the EEG and 
behavioral manifestations of slow wave sleep were not altered by an intravenous infusion 
of 1 *S ml of physiologic saline solution warmed to body temperature. If cold solutions 
and/or rapid injection of large volumes were given, the animals could be aroused from 
slow wave sleep. Therefore, it was particularly important that the solutions administered 
were warmed and given slowly. 
B. Eflects of nicotine 
1. Szhgle doses. The intravenous infusion of nicotine {0.~5~*01 mg/kg) over a 
l-mm period in slow wave sleeping cats produced three distinct electroencephalographs 
and behavioral responses. These were: (a) electroencephalographic and behaviorai 
:Kindly provided by Dr. E. GLOCK, Department of Research and Development, American Tobacco 
Company, Richmond, Virginia. 
l/KindIy provided by Dr. K. %XCSON, Unimed, Inc., Morristown, New Jersey. 
**Kindly provided by Dr. R. BIRCHER, Sandoz, Inc., Pharmaceutical Division, Hanover, New Jersey. 
TtKindly provided by Dr. R. F. PARCELL, Parke Davis Research Laboratories, Ann Arbor, Michigan. 
JfKindly provided by Dr. R. F. TIS~W, Wyeth Laboratories, Inc., Philadeip~a, Pennsylvania, 
~~KindIy provided by Dr. C. STONE, Merck Institute for Therapeutic Research, Merck and Company, Inc., 
West Point, Pennsylvania. 
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9 MIN JIM!& 
EJG. I. EECi effects of nicotine in the cat with chronic indwelling brain electrodes. Nicotine 
was given between the two arrows during slow wave (deep) sleep. Note changes in EEG 
activity and behavior. The upper two records are continuous. The lower are 9 and 15 min 
Iater. Ah recordings were bipolar. Symbols: L. POST. Sm.--left posterior sigmoid gyrus; 
AMG.-amygdala; POST. Hun.-posterior hypothalamus; HIP.-hippocampus; EKG.- 
electrocardiogram; EMG-electromyograph of neck muscles; RESP.-thoracic respiration. 
Time bases and voltage calibrations are as indicated. These symbols when used apply to 
all subsequent figures. 
arousal immediately following the nicotine injections, (b) a few min later, a subsequent 
stage of slow wave sleep and, (c) the occurrence of activated sleep. The EEG manifesta- 
tions of these three stages in one animal are illustrated in Fig. 1. Bipolar EEG activity 
was recorded from the posterior sigmoid gyrus, amygdala, posterior hypot~lamus and 
~ppocampus as well as the EKG, EMG of neck muscles and thoracic respiration. In 
the period immediately prior to nicotine injection, the cat was in a slow wave sleeping state. 
This was evidenced by the occurrence of EEG slow waves and spindle bursts in the posterior 
sigmoid gyrus, high voltage slow waves and spikes in the amygdala, and hippocampal 
fast activity. In addition, respiration was slow and regular. During this state nicotine 
(0.01 mg/kg) was given over a one-minute period. After approximately half of the injection, 
the cat showed evidence of head movement and behavioral arousal. This was preceded 
a few seconds earlier by low voltage, fast wave activity and typical theta rhythm in the 
hippocampus. The mean duration rfi SE. for the EEG and behavioral manifestations of 
arousal was 2.93 f O-52 min. Subsequently, the cat began to relax and returned to his 
previous slow wave sleeping state. It was noted that frequently this state was much 
deeper and more persistent than prior to nicotine administration. A portion of the EEG 
tracing taken 9 min after intravenous nicotine infusion is illustrated in Fig. 1. At this 
time the animal showed more evident EEG ~nifestat~ons of the slow wave sleeping state. 
Approximately 15 min after the intravenous infusion of nicotine the cat lapsed into activated 
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sleep as evidenced by low voltage, fast wave activity in the posterior sigmoid gyrus, amygdala, 
and posterior hypothalamus. At the same time the hippocampus showed marked theta 
activity. The EMG of the neck muscles completely disappeared, respiration and heart rate 
were irregularly increased. 
It is of considerable interest that the EEG manifestations of arousal following nicotine 
nfusion usually were first evident in the hippocampus. Neocortical and amygdaloid 
EEG activation occurred a few seconds after the initiation of hippocampal theta rhythm. 
Following nicotine injection high voltage, rhythmic theta waves were obtained. This 
is in contrast to similar activity occurring in this structure in the cat which arouses spon- 
taneously. Under these circumstances the amplitude of the hippocampal theta rhythm 
as well as its sinusoidal form is not as marked. The marked ~ppocampal EEG activity 
following nicotine ad~nistration suggests a strong activation of this system. Neocortical 
and amygdaloid EEG activation usually Iagged behind the induced hippocampal theta 
activity. The high voltage rhythmic bursts in the amygdala, which are frequently 
seen in excited cats, were observed following nicotine administration. It is of interest that 
behavioral arousal due to nicotine usually was evident a few set after EEG activation. 
The behavioral manifestations of arousal following nicotine administration included 
opening of the eyelids, snillmg, picking up and turning the head and occasionally standing. 
At no time was there evidence of nausea and emesis. A marked increase in respiratory 
exchange, EMG activity as well as an increase in blood pressure and alteration in heart 
rate were also noted. The physiologic and EEG manifestations 20 min prior to as well as 
20 min after nicotine injection for the same cat as in Fig. 1 are plotted graphically in Fig. 2. 
FIG. 2. Graph of the effects of nicotine. 
It can be seen that prior to nicotine infusion the cat’s EEG patterns ffuctuated between 
the resting state, drowsiness, and SIOW wave (deep) sleep. Occasionally a brief period of 
activated sleep was observed during which EKG and respiration showed minor fluctuations. 
Following nicotine infusion intravenously in a dose of 0.01 mg/kg, marked respiratory 
stimulation, bradycardia and evidence of EEG activation and behavioral alertness was 
obtained. Within 5 min this was followed by a more consistent pattern of deep sleep and 
subsequently (15-30 min) by a stage of activated sleep. 
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In an attempt to quantify some of these findings, the percentage of time spent in different 
EEG stages of sleep were analyzed 5 min prior to as well as 5 min after nicotine injection. 
The data for a series of 9 animals given nicotine as well as other treatments are summarized 
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FIG. 3. Mean percent time -& S.E. in different EEG states 5 min before and after various 
tr~tments. 
spent in deep sleep was much greater (62.1 per cent) than in the other states simply 
because the time of drug injection was determined by the presence of deep sleep. After 
saline solution injection the animals continued in the drowsy and/or deep sleeping state 
and thus showed a minimum of wakefulness. In contrast, the intravenous injection of 
nicotine caused a marked increase in EEG and behavioral arousai which was highly signi- 
ficant (P<*OOi). This was associated with a decrease in drowsiness and deep sleep 
(P< *OOl). 
2. Effects of repeated doses. Marked tachyphylaxis to the blood pressure increase, 
stimulation of respiration as well as behavioral and electroencephalograp~c arousal were 
obtained if nicotine was administered repeatedly at time intervals of Iess than 30 min. 
When nicotine was given in a dose of 0*005 mglkg at a one&r interval reproducible EEG 
and behavioral arousal were obtained. However, marked tachyphylaxis to the respiratory 
stimulant effects of nicotine were still evident (see Fig. 4). If nicotine was administered 
at a two&r interval no evidence of tachyphylaxis was obtained to any of the physiologic 
parameters measured (Fig. 5). 
C. Eflects of various derivatives of nicotine on EEG and behavior 
The effects of (+) nicotine, nicotine-N-oxide, and cotinine were compared with (-) 
nicotine on the basis of equal dosage (0.01 mg/kg) and also on the basis of doses producing 
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FIG. 4. Graph of the effects of nicotine given at I-hr intervals. 
Note tach~hy~~is of respiratory stimulation but not EEG arousal 
to repeated hourly injections of nicotine. 
FIG. 5. Graph of the effects of nicotine given at 2-hr intervals. Note lack of tachyphylaxis. 
an equipressor response. The increase in blood pressure usuafly obtained with (-) 
nicotine was in the order of 60-70 mm mean Hg pressure. In doses of 0.01 mg/kg given 
intravenously (+) nicotine did not produce any change in blood pressure nor was there 
E 
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alteration of the EEG or gross behavioral pattern in deeply sleeping cats. On the other 
hand, equipressor doses of (-+) nicotine (O-05 mgjkg) produced transient EEG activation 
and behavioral arousal. The mean duration -& SE. of I’+) nicotine EEG activation was 
1.34 & 0.25 min. Behavioral arousal induced by (+) nicotine was much weaker than 
that of (-) nicotine. In addition, in equipressor amounts, respiratory stimulation produced 
by the (-i-) isomer was not as marked. As was observed after (-) nicotine slow wave 
and activated sleep foflowed the initial arousal phase, 
In doses of 0.01 mg/kg nicotine-N-oxide did not produce any increase in blood pressure 
or affect the EEG and behavior of deeply sleeping cats. On the other hand, equipressor 
doses of nicotine-N-oxide (1.5 mg/kg) showed transient EEG activation and behavioral 
arousal from the deeply sleeping state. The mean duration & S.E. of nicotine-N-oxide 
induced EEG activation was O-95 & 0.22 min when given in doses of 1.5 mg/kg intraven- 
ously. In contrast to the effects of (-) nicotine respiratory stimuIation was not as evident 
with nicotine-N-oxide. 
Doses of 0.01 mg/kg of cotinine did not affect the EEG or behavior of deeply sleeping 
cats. On the other hand, doses of 10 mg/kg given intravenoudy showed transient EEG 
activation and behaviora arousal although such doses did not produce any change in 
blood pressure. Larger doses of cotinine in the order of 25 mgjkg intravenously produced 
a slight fall in blood pressure. Suck large doses of cotinine also produced brief episodes 
of EEG activation and behavioral arousal (see Fig. 6). The mean duration rl_. S.E. of 
cotinine-induced EEG activation was I 953 f 0.24 min. 
Fig. 6. Graph of the effects of increasing doses of cotinine. 
The quaternary gangfionic stimulant, DMPP, was used to mimic the peripherai actions 
of nicotine. Doses of 04305 mg/kg of DMRP caused pressor responses equivalent to those 
produced by 0*01 mg/kg of (--) nicotine given intravenously. In such equipressor doses 
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DMPP produced mini~l EEG activation and behavioral arousal in deepiy sleeping cats. 
InterestingIy, respiratory stim~ation was minimal. The mean duration rt SE. of DMPP- 
induced EEG activation was l-39 -& 0.48 min. 
D. Eflects of some neurohutnoraf agents released by nicotine on EEG and behavior 
Nicotine is known to release various neurohumoral substances including E, vasopressin, 
serotonin, and histamine. The effects of these substances in maximal amounts which 
could be reasonably released by nicotine were tested on behavioral and EEG arousal in 
deeply sleeping cats. 
1. Epinephrine (E). Doses of 0.002 mg/kg of E given intravenously produced equiva- 
lent pressor responses to 0.01 mg/kg of (-) nicotine. These amounts of E produced 
behavioral and EEG arousal in deeply sleeping cats. The mean duration & SE. of EEG 
activation foilowing E injection was 1.95 4 0.19 min. In contrast to the effects of equi- 
pressor doses of nicotine, behavioral arousal induced by E was limited to the animals 
opening their eyes or picking up their heads. Respiratory stimulation was not as marked 
as with nicotine itself. Thus, the overall effects of equipressor doses of E were far weaker 
than those obtained with nicotine. 
2, Vusoprexsin. In a dose of 50 milliunits/kg synthetic phenylalanyl lysyl vasopressin 
produced a pressor response comparable to 0.01 mg/kg of (-) nicotine. Following the 
administration of vasopressin in the blood pressure continued to be elevated for approxi- 
mately 6-8 min. During the pressor response a marked bradycardia was observed. EEG 
activation was obtained following intravenous injection of vasopressin, but spindle bursts 
reappeared while the blood pressure was still maintained. Vasopressin did not produce 
as dramatic a behavioral arousal compared to E and especially (-) nicotine. The mean 
duration i: S.E. of vasopressin-induced EEG activation was I *63 + 0.18 min. A parti- 
cularly important finding following vasopressin administration was the marked percentage 
increase in the appearance of activated sleep. 
3. Serotonin. Doses of 0,022 mg/kg of serotonin produced approximately a 39 mm Hg 
fall in blood pressure when given intravenously. The EKG showed an initial bradycardia 
and a secondary tachycardia. Respiratory stimuIation was evident. During this time 
the cat showed EEG activation and behavioral arousal. The mean duration f S.E. of 
serotonin-induced EEG activation in five cats was 4.20 & 0.42 min. Subsequently, the 
cats fell into a light sleep behaviorally and electroencephalographically. Slow wave sleep 
was seen after the administration of serotonin but activated sleep was never seen within 
25 min after injection. 
4. Histamine. Doses of O=OOl mgjkg of histamine produced only a tachycardia in 
cats in slow wave sleep but did not alter the EEG and behavioral state. Within 5 min after 
injection the cats showed even slower wave patterns. Doses of 0.002 mg/kg of histamine 
produced a more marked tachycardia and hypotension of approximately 45 mm Hg, 
This was associated with a mean & SE. EEG and behavioral arousal of 2.44 i_ 0.66 min 
in seven cats. Subsequently, the cats lapsed into slow wave sleep. Activated sleep was not 
seen within 20 min after histamine, in contrast to nicotine and vasopressin injections. 
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E. ~od~~cation #~nic~tine-induced EEG and be~avi~r~i arousal by various gartglimic 
blocking agents 
In an attempt to dissociate the peripheral and central contributions of (-) nicotine in 
causing EEG and behavioral arousal two different ganglionic blocking agents were used 
as pretreatments. One was the quaternary ganglionic blocking agent, trimethidinium. 
Because of the permanent positive charges on this compound, it would not be expected 
to penetrate the blood-brain barrier easily. The other ganglionic blocking agent used 
was the secondary amine, mecamylamine. This compound has been shown previously 
to block the central as well as peripheral actions of nicotine (KNAPP and DOMINO, 1962). 
The intravenous administration of trime~idinium (2 mg/kg) did not alter the EEG and 
gross behavior of deeply sleeping cats. There was, however, some increase in heart rate 
as would be expected from a ganghonic blocking drug. Pretreatment with trimet~dinium 
completely blocked the blood pressure elevating and bradycardic actions of nicotine. 
On the other hand, respiratory stimulation was still evident although somewhat reduced 
from control. Similarly, EEG activation and behavioral arousal produced by nicotine 
in the deeply sleeping cat still appeared as before trimethidinium pretreatment. The data 
obtained in one of the cats are plotted graphically in Fig. 7. Prior to trimethidinium 
FIG. 7. Modifi~tion of the effects of nicotine by trimethid~i~. Note that the respiratory 
stimulant and EEC arousal effects are only partiaily blocked, 
administration, nicotine produced the characteristic physiologic alterations including 
EEG activation as illustrated. After trimethidinium administration heart rate was markedly 
increased. Nicotine infusion in a dose of 0.01 mg/kg produced no subsequent alteration 
in heart rate, although respiratory stimulation was reduced. It was still possible to obtain 
EEG and behavioral arousal but this was not as intense as in the control situation. The 
mean duration of EEG and behavioral arousal f SE. to nicotine after trimethidinium 
was 2.05 &- 0.29 min in comparison to nicotine alone which was 2.93 -& 0.52 min. In 
contrast to the lack of effects of trimethidinium, doses of m~amyla~ne in the order of 
2 mg/kg given intravenously prevented naturally occurring sleep. After such doses of 
mecamylamine, the animals would lay on their sides but did not show characteristic deep 
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sleep. Instead the electroencephalographic pattern was one of desynchronization. There- 
fore the effects of low doses of mecamylamine in modifying nicotine actions were deter- 
mined. It was found that doses of 06 mg/kg of mecamylamine did not affect the EEG or 
gross behavior of deeply sleeping cats. Therefore this was used for premeditation. As 
might be expected, following mecamylamine administration all of the effects of 0.01 mg/kg 
of nicotine were blocked. These are graphically illustrated in one typical experiment in 
Fig. 8. Prior to mecamylamine administration, a dose of 0.01 mg/kg of nicotine produced 
the usual EEG and behavioral alterations as well as respiratory stimulation. On the other 
hand, after 0.6 mg/kg of mecamylamine, nicotine had no significant effect. 
4LERT 
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FIG. 8. Modification of the effects of nicotine by mecamylamine. Note that all of the effects 
of nicotine are blocked. 
DISCUSSION 
The purpose of this research was to test two alternate hypotheses: (a) that the EEG 
desynchronizing effects of nicotine were accompanied by behavioral arousal or (b) that 
such EEG desynchronization represented a stage of activated sleep. The use of cats with 
chronic indwelling brain electrodes provided a means of testing these hypotheses. Such 
animals have a relatively normal sleep cycle and it was possible to record easily naturally 
occurring deep or slow wave sleep. In such a deeply sleeping state, the administration of 
nicotine in low doses intravenously caused prompt EEG activation and behavioral arousal. 
From these experiments it can be concluded that the initial effects of nicotine are to 
produce a behavioral wake up effect. The results of these experiments are in agreement 
with the data obtained in acute animals by KNAPP and DOMINO (1961-1963). The latter 
investigators showed that nicotine produced EEG desynchronization in intracollicular 
midpontine brainstem transected preparations. Inasmuch as nicotine injection altered 
the electrical activity of the isolated reticular slab, a pontomesencephalic site of action for 
the EEG activating effect of nicotine was proposed. In contrast FLORIS et al. (1962) 
showed that large doses of nicotine continued to produce activation or seizures following 
mesencephalic transection in rabbits. They pointed out that EEG convulsive activity 
was more prolonged and intense in the hippocampus rather than neocortex and 
suggested that such discharges originated in the hippocampus. Their findings also 
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are reminiscent of earlier work by DUNLOP et al. (1960) who reported that of three 
regions (hippocampus, neocortex and reticular formation) examined in rabbits the 
hippocampus had the lowest threshold for nicotine-induced seizure discharges. Further- 
more, a few seconds after nicotine injection there was often observed an increased firing 
of neuronal units that were synchronous with the hippocampal EEG theta activity. These 
phenomena were obtained with relatively large doses of nicotine so that there is some 
question as to whether they are applicable to low doses of nicotine that produce EEG 
activation alone. However, in the present study it was found that EEG desynchronization 
in the neocortex usually followed by several set the appearance of hippocampal theta 
activity. At the same time 35-45 c/s burst discharges were recorded in the amygdala. 
This was accompanied by behavioral sniffing. The appearance of hippocampal theta 
rhythm before characteristic neocortical EEG desynchronization suggests that the hippo- 
campus is exquisitely sensitive to the actions of even small doses of nicotine. 
The possibility that nicotine-induced EEG desynchronization is secondary to stimula- 
tion of respiratory medullary areas or to blood pressure elevation was ruled out by several 
different experiments. Repeated administration of nicotine at one-hour intervals produced 
tachyphylaxis to the respiratory stimulant effects although EEG activation still occurred. 
This clearly dissociates the site of action of EEG activation of nicotine from its site for 
respiratory stimulation. EEG activation and behavioral arousal induced by nicotine 
were obtained after complete blockade of its cardiovascular effects following tremethi- 
dinium pretreatment. Similar results were obtained in midpontine transected animals by 
KNAPP and DOMINO (1962). The peripherally acting ganglionic stimulant DMPP elevated 
blood pressure to the same extent as nicotine. However, in equipressor doses DMPP 
produced much weaker EEG and behavioral arousal than nicotine itself. 
It might be argued that the EEG and behavioral arousal effects of nicotine were due 
primarily to the peripheral release of E or vasopressin. However, equipressor doses of E 
(0.002 mg/kg) or synthetic vasopressin (50 milliunits/kg) produced much weaker EEG and 
behavioral arousal than nicotine (0.01 mg/kg). Of course a study of the effects of naturally 
occurring arginine vasopressin are indicated. Nevertheless, these results strongly suggest 
a primary direct action of nicotine on the central nervous system. These results are also 
consistent with the findings of KNAPP and DOMINO (1962) who showed that in brainstem 
transected animals, EEG activation effects of nicotine were not mediated by epinephrine 
or vasopressin release. Inasmuch as nicotine is thought to release serotonin as well as 
histamine, it was possible that these substances could produce the initial EEG and 
behavioral arousal effects observed. However, relatively large doses of these substances 
were necessary to produce an arousal pattern which still was relatively weak so it seems 
unlikely that release of these substances accounts for the nicotine arousal phenomenon. 
Could the EEG activating effects of nicotine be due to its metabolic conversion to 
another substance? The best known metabolite of nicotine is (-) cotinine. In these 
experiments equal amounts of cotinine had no effect whatsoever. Relatively massive 
doses of cotinine were necessary to produce EEG and behavioral arousal. These were most 
consistently obtained with a total dose of 25 mg/kg given intravenously. Under these 
circumstances a very transient arousal was evident accompanied by slight fall in blood 
pressure. No significant respiratory stimulation was obtained. These cardiovascular 
findings agree with the results of BORZELLECA et al. (1962) who showed that 50 mg/kg 
of (--) cotinine caused a transient hypotension without respiratory changes in the pento- 
barbital anesthetized dog. It is of interest that cotinine does not penetrate into the central 
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nervous system as easily as nicotine (BOWMAN et al., 1964; HANSSON and SCHMITERLOW, 
1962). In contrast to the widespread distribution of C14-labeled nicotine in the mouse 
brain, tritium-labeled cotinine does not concentrate in the brain nearly as well. Other 
derivatives of nicotine such as nicotine-N-oxide and (+) nicotine were shown to be much 
less effective than nicotine in producing EEG desynchronization and behavioral arousal. 
One of the most intri~ing effects of nicotine administration to the deeply sleeping 
cat was that following a brief period of behavioral arousal and EEG des~ehronization, 
the animals lapsed into a deeper state of naturally occurring sleep and a subsequent phase 
of activated sleep. JOUVET (1961) suggested that the induction of activated sleep depends 
upon neurotransmitter substances of a cholinergic nature. Furthermore, PEON (1964) 
used cats with chronic indwelling brain cannulae to show that slow wave as well as activated 
sleep could be obtained by the injection of cholinergic substances directly into the brain 
in the area of the limbic midbrain circuit of NAUTA (1958). SEKUL and HOLLAND (1961) 
have pointed out that nicotine has an obvious structural chemical resemblance to acetyl- 
choline in that the spatial distribution of charges in the molecule are somewhat similar. 
Inasmuch as historically nicotine has been used to demonstrate the ‘nicotinic’ sites of 
action of acetylcholine, it seems reasonable to suggest that the actions of low doses of 
nicotine are probably related to stimulation of cholinergic receptors. This suggestion is 
further strengthened by the use of agents which produce selective nicotinic blockade. 
For example, ganglionic blocking agents which block the nicotinic actions of acetyl- 
choline are also extremely effective in blocking the actions of nicotine. It has been shown 
in these series of experiments that a ganglionic blocking agent (mecamylamine) which 
can penetrate the bloodbrain barrier blocks both the central as well as peripheral actions 
of nicotine. This is in contrast to the effects of trimethidinium which only blocked the 
peripheral actions of nicotine but not its central effects, presumably because trimethidinium 
cannot penetrate into the brain in sufficient dosage to block nicotinic receptors. 
It has been shown that following the brief period of nicotine-induced behavioral arousal 
a subsequent period of enhanced slow wave sleep and activated sleep are evident. Some 
of these effects, particularly the facilitation of activated sleep, was produced by synthetic 
phenylalanyl lysyl vasopressin. Inasmuch as nicotine is known to release large quantities 
of natural occurring argininine vasopressin, it appears that this neurohormone may be 
involved in the e~ancement of activated sleep following nicotine. Further research 
along these lines is now being carried out. 
R6sum&-Chez le chat, porteur d’&ctrodes c&ebraIes a demeure, la nicotine ( - ) & des doses 
de 0405-0~01 mg/kg en administration intrateineuse pendant I min, entrahte un &veil com- 
portemental et une activation EEG transitoires. Les effets de la nicotine sont particulierement 
evidents chez le chat en &tat de sommeil natural, profond (avec ondes lentes) ainsi qu’il a CtC 
observe tant du point de we du comportement que de I’EEG derive de differentes aims corti- 
tales et sous-corticales. Aprbs administration de nicotine, l’animal se reveille quelques minutes 
puis devient comportementalement endotmi avec presence d’ondes lentes. Cet ttat se pour- 
suit frequemment par un sommeil “active” avec des ondes rapides. Ce phenomene n’est pas 
evident a la suite d’une infusion de volumes egaux de solution saline chauffee. A dose &gale, 
la nicotine (+). oxyde de nicotine-N, et la coltinine sont sans eRet EEG ou comportemental 
SW le chat en sommeil B ondes lentes. Cependant, des doses Cquipressives de nicotine (+) 0.05 
mg/kg et d’oxyde de nicotine-N, I 5 mg/kg, d&erminent un leger eveil colnportemental et 
EEG chez I’animal en Btat de sommeil avec ondes lentes. 
Une posologie massive de cotinine (25 m&kg), par voie i.v., se rcvele moins e&ace qu’une 
dose de O-01 mg/kg de nicotine ( - ). Des doses 4quipressives ~~pin~phrine (E) 0.002 mg/kg, 
de vasopressine (50 mu/kg) et de DMPP (04X95 mg/kg) engendrent une activation EEG et un 
Cveil comportemental moins accentue que la nicotine ( -). 
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Un pretraitement par le trimethidinium (2 mg/kg) previent les effets eardiovasculaires de la 
nicotine sans alterer significativement ses effets d’kveil comportemental ou d’activation EEG. 
D’autre part, la m~myla~ne (0.6 mg/kg) entraine un blocage complet des effets cardio- 
vasculaires de la nicotine de m8me que son action sur I’EEG et le com~rtement. 
Des doses sup&ieures de m~mylam~e interferent avec le cycle nature1 de sommeil du 
chat. ~utilisation de ces techniques pha~a~logiques permettent de conclure a des effets 
d’eveil comportemental et de d~s~chroni~tion EEG de la nicotine qui seraient dus essentielle- 
ment a une action sur le systeme nerveux central plut8t qu’a une stimulation peripherique a%- 
rente ou a une liberation de differentes neurohormones. Ces demiers effets contribuent 
cependant au phenomene global induit par la nicotine chez l’animal intact. 
Zusanunenfassung-(-) Nikotin verursachte in Dosen von 0~005-0~01 mg/kg, die ueber eine 
Minute intravenoes gegeben wurden, voruebergehendes Aufwachen und EEG Aktiviemng 
in Katzen mit Dauer-Himelektroden. Der Nikotineffekt war erkennbar, wenn sich die 
Tiere in natuerlichem, durch langsame Himwellentaetigkeit gekennzeichnetem Schlaf 
befanden. Das Aufwachen wurde auf Grund der Verhaltensweise des Tieres und mit Hilfe 
von corticalen und subcorticalen Elektroden registriert. Nach Verabfolgung de Nikotin 
erwachten die Tiere fuer einige Mint&en, wurden dann wieder schlaefrig mit im EEG erkenn- 
barer langsamer Himwellen-Taetigkeit. Dies war oft gefolgt von aktiviertem, durch schnehe 
Himwellentaeti~eit gekennzeichnetem Schlaf. Dieses Phenomen war nicht erkennbar, wenn 
gleiche Mengen warmer Kochsalzloesung verabfolgt wurden. Gleiche Dosen von (+I 
Nikotin, Nikotin-N-Oxyd und Cotinine hatten keinen Effekt auf das EEG tmd das 
Ver~lten von Katzen, die sich in von langsamer Himwellen-Taeti~eit geke~~ic~eten 
Schlaf befanden. Dosen von (+) Nikotin (O-05 mg/kg) und Nikot~-N-Oxyd (I 5 mg/kg) 
mit gleichem Pressoreffekt bewirkten jedoch leichtes Aufwachen, gekennzeichnet durch das 
Verhalten des Tieres und durch das iangsame Himwel~ent~tigkeit zeigende EEG. Hohe 
DOWI von Cotinine (25 mg/kg), intravenoes verabfolgt, waren weniger wirkungsvoll as 
(-1 Nikotin in Dosen von 0.01 mg/kg. Dosen von Epinephrine (0402 mg/kg), Vasopressin 
(50 Millieinheiten/kg) und DMPP (0405 mg/kg) mit gleichem Pressoreffekt verursachten 
schwaechere EEG Aktivienmg und geringeren Aufwacheffekt als (-) Nikotin. 
Vorbehandlung mit Trimethidinium (2 mg/kg) verhinderte das Auftreten von dendurch 
cardiovaskulaeren Effekten Nikotin erzeugten, aenderte jedoch wenig den Aufwacheffekt 
oder die Wirkung auf die EEG Aktivierung. Dagegen fuehrte Mecamylamine (0.6 mg/kg) 
zu einem kompletten Block der durch Nikotin verursachten cardiovaskulaeren Effekte und 
des Aufwacheffekts. Hoehere Dosen von Mecamylamine stoerten den natuerlichen Schlaf- 
zyklus der Katze. Die Anwendung einer solchen pharmakologischen Methode laesst den 
Schluss zu, dass die im Aufwachverhalten und im EEG registrierte desynchronisierende 
Wirkung des Nikotin in erster Linie der Erfolg eines Effektes auf das Zentralnervensystem ist 
und weniger mit einer peripheren afferenten Reizung oder mit der Wirkung verschiedener 
Nervenhormone im Zusa~enh~g steht. Letztere tragen jedoch zu dem durch Nikotin 
im intakten Tier verursachten Phenomen bei. 
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